近视角膜屈光手术后人工晶状体度数计算新公式的开发与验证
本研究基于134例近视角膜屈光手术患者开发了厚透镜LISA MRS公式,用于预测术前前角膜曲率半径以估算有效晶状体位置,并在三家中心的225例有近视角膜屈光手术史的白内障患者中验证。结果显示LISA MRS公式的性能指数最高(0.43),在眼轴≥28 mm时仍保持较好准确性,建议纳入后角膜曲率半径。
要点
- LISA MRS公式在有近视角膜屈光手术史的白内障患者中预测误差最低。
- 后角膜曲率半径可显著提升Barrett True K、LISA MRS和Hoffer QST的性能。
- 眼轴≥28 mm时LISA MRS公式仍保持较好准确性。
核心结论
- LISA MRS公式能为有近视角膜屈光手术史的白内障患者提供准确的人工晶状体度数计算,尤其在眼轴≥28 mm时。
- 建议在可获得时使用后角膜曲率半径。
研究设计与样本
- 回顾性比较性分析,纳入134例近视角膜屈光手术患者(98例SMILE,36例FS-LASIK)开发公式,并在三家中心的225例有近视角膜屈光手术史的白内障患者中验证。
- 采用线性回归模型描述术前前角膜曲率半径与术后后角膜曲率半径的关系,并开发厚透镜LISA MRS公式。
主要发现
- 术后后角膜曲率是术前前角膜曲率半径的强预测因子,R²为0.82。
- 在225例验证患者中,LISA MRS(含或不含后角膜曲率半径)的性能指数最高(0.43),其次为Hoffer QST(0.37)、EVO和Hoffer QST-PRC(均为0.32)、EVO-PRC和Barrett True K-PRC(均为0.30)、Barrett True K(0.26)。
- LISA MRS-PRC和EVO-PRC的中位绝对预测误差最低(0.47 D),EVO-PRC在眼轴<28 mm时表现相对更好,LISA MRS-PRC在眼轴≥28 mm时保持较好准确性。
- 纳入后角膜曲率半径显著改善了Barrett True K、LISA MRS和Hoffer QST的性能(均P < .05)。
关键数值与推荐
- LISA MRS公式(含或不含后角膜曲率半径)性能指数为0.43。
- LISA MRS-PRC和EVO-PRC的中位绝对预测误差为0.47 D。
- 纳入后角膜曲率半径改善Barrett True K、LISA MRS和Hoffer QST的性能,均P < .05。
临床怎么用
- 对有近视角膜屈光手术史的白内障患者,可选用LISA MRS公式计算人工晶状体度数。
- 当可获得后角膜曲率半径时,建议纳入计算以提升准确性。
- 对于眼轴≥28 mm的患者,LISA MRS-PRC可能更具优势。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To develop and validate a new intraocular lens (IOL) power calculation formula for cataract patients with previous myopic corneal refractive surgery (MRS). DESIGN: Retrospective, comparative analysis of lOL power calculations. PARTICIPANTS: Patients undergoing MRS were enrolled for formula development, and cataract patients with prior MRS were recruited for evaluation. METHODS: Linear regression model was used to characterize the relationship between preoperative anterior corneal radius (ARC) and postoperative posterior corneal radius (PRC) in patients undergoing MRS. A thick-lens LISA MRS formula was then developed, using predicted preoperative ARC for effective lens position estimation. Its performance was compared with existing formulas (Barrett True K, Emmetropia Verifying Optical [EVO], Haigis-L, Hoffer QST, and Shammas PL) in cataract patients with prior MRS. MAIN OUTCOME MEASURES: Arithmetic and absolute prediction errors. RESULTS: The study included 134 MRS patients (98 small incision lenticule extraction [SMILE] and 36 femtosecond laser-assisted in situ keratomileusis [FS-LASIK]) for formula development, and the changes in anterior and posterior keratometry were comparable between the two procedures. Postoperative PK was a strong predictor of preoperative ARC, with an R2 of 0.82. In 225 cataract patients from three centers for formula validation, the formula performance index (FPI) was highest for LISA MRS (with or without PRC, 0.43), followed by Hoffer QST (0.37), EVO and Hoffer QST-PRC (both 0.32), EVO-PRC and Barrett True K-PRC (both 0.30), and Barrett True K (0.26). LISA MRS-PRC and EVO-PRC yielded the lowest median absolute prediction error (0.47 D), with EVO-PRC performing relatively better in eyes with AL < 28 mm and LISA MRS-PRC maintaining favorable accuracy in eyes with AL ≥ 28 mm. Incorporating PRC significantly improved the performance of Barrett True K, LISA MRS, and Hoffer QST (all P < .05). CONCLUSIONS: The LISA MRS formula provides accurate IOL power calculation for cataract patients with prior MRS, particularly in eyes with AL ≥ 28 mm. Use of PRC is recommended whenever available.
引用
- Zhang J, Xie X, Yuan H, et al. Development and Validation of a New Formula for Intraocular Lens Power Calculation in Patients With Myopic Corneal Refractive Surgery. Am J Ophthalmol. 2026. PMID: 41819516. doi:10.1016/j.ajo.2026.03.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。